Suppression of Bilirubin Production in the Crigler-Najjar Type I Syndrome: Studies with the Heme Oxygenase Inhibitor Tin-Mesoporphyrin

Richard A. Galbraith; George S. Drummond; Attallah Kappas

Article

Suppression of Bilirubin Production in the Crigler-Najjar Type I Syndrome: Studies with the Heme Oxygenase Inhibitor Tin-Mesoporphyrin

Richard A. Galbraith, George S. Drummond and Attallah Kappas

Pediatrics February 1992, 89 (2) 175-182;

Richard A. Galbraith

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

George S. Drummond

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Attallah Kappas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
Comments

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

Advertising Disclaimer »

In this issue

Pediatrics

Vol. 89, Issue 2

1 Feb 1992

Table of Contents
Index by author

PreviousNext

Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Suppression of Bilirubin Production in the Crigler-Najjar Type I Syndrome: Studies with the Heme Oxygenase Inhibitor Tin-Mesoporphyrin

Message Subject (Your Name) has sent you a message from American Academy of Pediatrics

Message Body (Your Name) thought you would like to see the American Academy of Pediatrics web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Request Permissions

Article Alerts

You will be redirected to aap.org to login or to create your account.

Or Sign In to Email Alerts with your Email Address

Email *

Citation Tools

Suppression of Bilirubin Production in the Crigler-Najjar Type I Syndrome: Studies with the Heme Oxygenase Inhibitor Tin-Mesoporphyrin

Richard A. Galbraith, George S. Drummond, Attallah Kappas

Pediatrics Feb 1992, 89 (2) 175-182;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Suppression of Bilirubin Production in the Crigler-Najjar Type I Syndrome: Studies with the Heme Oxygenase Inhibitor Tin-Mesoporphyrin

Richard A. Galbraith, George S. Drummond, Attallah Kappas

Pediatrics Feb 1992, 89 (2) 175-182;

Share This Article:

Download PDF

Insight Alerts

Table of Contents

Jump to section

Article
Info & Metrics
Comments

No related articles found.

PubMed
Google Scholar

Cited By...

A Nanoceutical Agent for Chemoprevention of Bilirubin Encephalopathy
Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer
Pharmacological and Clinical Aspects of Heme Oxygenase
Pharmacology Review: Tin Mesoporphyrin for the Prevention of Severe Neonatal Hyperbilirubinemia
A Method for Interdicting the Development of Severe Jaundice in Newborns by Inhibiting the Production of Bilirubin
Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs
Zinc Protoporphyrin: A Metabolite with a Mission
Control of Severe Hyperbilirubinemia in Full-term Newborns With the Inhibitor of Bilirubin Production Sn-Mesoporphyrin
Lack of Deafness in Crigler-Najjar Syndrome Type 1: A Patient Survey
Zinc porphyrins: Potent inhibitors of hematopoieses in animal and human bone marrow

Google Scholar

Main menu

User menu

Search

Suppression of Bilirubin Production in the Crigler-Najjar Type I Syndrome: Studies with the Heme Oxygenase Inhibitor Tin-Mesoporphyrin

Plain text

Vertical Tabs

Jump to comment:

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles